This trial will test the safety and feasibility of using a microdevice to measure local response to chemotherapy and other drugs in brain tumors.
- Grade II Brain Tumor
- Anaplastic Oligodendroglioma
- Anaplastic Astrocytoma
- Grade III Brain Tumor
2 Primary · 2 Secondary · Reporting Duration: 1 Day
1 Treatment Group
1 of 1
12 Total Participants · 1 Treatment Group
Primary Treatment: Microdevice · No Placebo Group · Phase < 1
Who is running the clinical trial?
Age 18+ · All Participants · 9 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
What is the present size of this trial's participant pool?
"Affirmative. According to clinicaltrials.gov, this medical experiment has been actively recruiting since it was first posted on March 3rd 2020 and last modified on February 26th 2023. It seeks out 12 participants at one particular site." - Anonymous Online Contributor
Are there any empty slots left in this experiment for volunteers?
"According to clinicaltrials.gov, this study is actively enrolling participants. It was initially advertised on March 3rd 2020 and the most recent update occurred on February 26th 2023." - Anonymous Online Contributor